Azithromycin shows lower COPD flare-up rates over one year than roflumilast

Multiple treatments are disposable for chronic obstructive pulmonary illness (COPD), but identifying which regimen champion matches an idiosyncratic patient's needs remains 1 of the biggest challenges successful care. A caller survey from researchers astatine UCLA Health compares 2 attraction options aimed astatine preventing exacerbations successful patients with COPD.